Organisation paid for research Program year 2025 Source: CMS Open Payments

Dana Farber Mass General Brigham

Neither a doctor nor a teaching hospital

Research payments

$69,065

28 payments

Through program year 2025, Dana Farber Mass General Brigham is reported as receiving $69,065 in research payments, across 28 payments.

By program year

3 rows

Year	Kind	Amount	Payments
2025	Research	$27,721	12
2024	Research	$5,330	5
2023	Research	$36,014	11

Breakdown

Who paid Research payments · program years 2023–2025

GlaxoSmithKline, LLC. $36,014 11 payments
Global Blood Therapeutics, Inc. $19,966 10 payments
Array BioPharma Inc. $13,085 7 payments

Studies the money was for Research payments · program years 2023–2025

An Openlabel Extension Study to Evaluate the Longterm Safety of Inclacumab Administered to Participants With Sickle Cell Disease Who Have Participated in An Inclacumab Clinical Trial $16,456 8 payments
A Multicenter Observational Study of Patients Receiving Systemic Treat $14,196 1 payment
A Phase 2 Openlabel Study of Encorafenib Binimetinib in Patients With Brafv600mutant Nonsmall Cell Lung Cancer $13,085 7 payments
214647 $11,706 4 payments
An Open-Label, Multicenter, Long-Term Treatment Extension Study in Sub $5,905 3 payments
A Randomized Doubleblind Placebocontrolled Multicenter Study to Assess the Safety and Efficacy of Inclacumab in Participants With Sickle Cell Disease Experiencing Vasoocclusive Crises $3,510 2 payments
A Phase 1 Dose Escalation and Cohort Expansion Study of Tsr-022, An An $2,481 2 payments
A Randomized, Double-Blind, Adaptive, Phase II/III Study of Gsk3359609 $1,726 1 payment

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.